Literature DB >> 23105678

Calcineurin activity in children with Mental handicap.

L Hema Bindu1, P Usha Rani, P P Reddy.   

Abstract

Calcineurin, a Ca(2+)-Calmodulin dependent protein phosphatase, is important for Ca(2+) mediated signal transduction. The main objective of this study was to examine the potential role of calcineurin in idiopathic mental handicap. Calcineurin levels were estimated in 20 children in the age group of 5-16 years with idiopathic mental handicap attending the Special. Education Centre for the Mentally Handicapped in Hyderabad. The results of the present study showed decreased activity of serum calcineurin in children with idiopathic mental handicap compared to those of normal subjects in the same age group. The observations thus suggest impaired calcineurin activity in children with mental handicap. Calcineurin that is involved in biosynthesis and release of neurotransmitters at the synaptic terminal brain is affected thereby causing brain damage and leading to mental handicap. Impaired calcineurin activity was already indicated in many human diseases such as Down's syndrome, Alzheimers, Brain ischemia, cardiac hypertrophy etc. It is therefore necessary to check the calcineurin levels in children with mental handicap to understand the role of calcineurin in the causation of Mental handicap.

Entities:  

Keywords:  CaN Inhibitors; Calcineurin; Calmodulin; Mental Handicap; Neurotransmitters

Year:  2007        PMID: 23105678      PMCID: PMC3453820          DOI: 10.1007/BF02913309

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  21 in total

Review 1.  Calcineurin as a multifunctional regulator.

Authors:  Futoshi Shibasaki; Ulrika Hallin; Hiroyuki Uchino
Journal:  J Biochem       Date:  2002-01       Impact factor: 3.387

2.  Identification of the Ca2+-dependent modulator protein as the fourth subunit of rabbit skeletal muscle phosphorylase kinase.

Authors:  P Cohen; A Burchell; J G Foulkes; P T Cohen; T C Vanaman; C Nairn
Journal:  FEBS Lett       Date:  1978-08-15       Impact factor: 4.124

3.  Decreased activity and increased aggregation of brain calcineurin during aging.

Authors:  Abdulbaki Agbas; Asma Zaidi; Elias K Michaelis
Journal:  Brain Res       Date:  2005-09-08       Impact factor: 3.252

4.  Expression of calcipressin1, an inhibitor of the phosphatase calcineurin, is altered with aging and Alzheimer's disease.

Authors:  Casey N Cook; Matthew J Hejna; Debra J Magnuson; John M Lee
Journal:  J Alzheimers Dis       Date:  2005-09       Impact factor: 4.472

5.  Protective effect of calcineurin inhibitors on acoustic injury of the cochlea.

Authors:  Isao Uemaetomari; Keiji Tabuchi; Tomofumi Hoshino; Akira Hara
Journal:  Hear Res       Date:  2005-08-09       Impact factor: 3.208

Review 6.  Neurotoxicity of calcineurin inhibitors: impact and clinical management.

Authors:  W O Bechstein
Journal:  Transpl Int       Date:  2000       Impact factor: 3.782

7.  Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421.

Authors:  Raúl Pardo; Emilie Colin; Etienne Régulier; Patrick Aebischer; Nicole Déglon; Sandrine Humbert; Frédéric Saudou
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

8.  Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation.

Authors:  David Hernández-Espinosa; A Jennifer Morton
Journal:  Brain Res Bull       Date:  2006-04-18       Impact factor: 4.077

9.  DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways.

Authors:  J J Fuentes; L Genescà; T J Kingsbury; K W Cunningham; M Pérez-Riba; X Estivill; S de la Luna
Journal:  Hum Mol Genet       Date:  2000-07-01       Impact factor: 6.150

10.  A calcineurin inhibitory protein overexpressed in Down's syndrome interacts with the product of a ubiquitously expressed transcript.

Authors:  H C S Silveira; C A Sommer; A Soares-Costa; F Henrique-Silva
Journal:  Braz J Med Biol Res       Date:  2004-05-27       Impact factor: 2.590

View more
  2 in total

1.  Calcineurin B stimulates cytokine production through a CD14-independent Toll-like receptor 4 pathway.

Authors:  Wu Wu; Qing Chen; Feng Geng; Li Tong; Rui Yang; Jinju Yang; Hongwei Zhang; Zongchao Jia; Qun Wei
Journal:  Immunol Cell Biol       Date:  2015-10-16       Impact factor: 5.126

2.  Identify Down syndrome transcriptome associations using integrative analysis of microarray database and correlation-interaction network.

Authors:  Min Chen; Jiayan Wang; Yingjun Luo; Kailing Huang; Xiaoshun Shi; Yanhui Liu; Jin Li; Zhengfei Lai; Shuya Xue; Haimei Gao; Allen Chen; Dunjin Chen
Journal:  Hum Genomics       Date:  2018-01-19       Impact factor: 4.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.